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Structure and Pharmacological Actions of Phys- 
alaemin, the Main Active Polypeptide of the Skin 
of Physalaemus fuscumaculatus1
It was shown2 that methanol extracts of the skin of the 
South American amphibian Physalaemus fuscumaculatus 
contain an eledoisin-like polypeptide which, like ele- 
doisin, exerts a powerful hypotensive action and stimu­
lates extravascular smooth muscle. This polypeptide, 
called physalaemin, has now been isolated in pure form 
and identified as the endecapeptide Pyr-Ala-Asp(OH)- 
Pro-Asp(NH2)-Lys-Phe-Tyr-Gly-Leu-Met-NH2.
Synthesis confirmed the above constitution3, closely 
resembling that of eledoisin4*5.
Isolation procedure and determination of structure. 471 
fresh skins of Physalaemus fuscumaculatus weighing 206 g 
and 323 dried skins weighing 32.8 g (physalaemin with­
stands drying perfectly) were extracted twice with 80% 
methanol. The combined filtered extracts were kept in 
a refrigerator and served as standard crude extract for 
the isolation of physalaemin.
The first step in the purification of physalaemin was 
the absorption of the crude polypeptide dissolved in 95% 
ethanol on alkaline alumina and subsequent elution with 
decreasing concentrations of ethanol. Physalaemin was 
eluted by 60% ethanol, whilst one or two minor active 
polypeptides were eluted with 80 and 70% ethanol.
Final purification was achieved by submitting the 
partially purified material to a double 40 transfers 
counter-current distribution using two n-butanol water 
systems with pH 2 and 9 respectively in the water phase. 
The yield was 70 to 80%.
Pure physalaemin was homogeneous in paper chro­
matography and electrophoresis, showing a single spot 
with ninhydrin, chlorine, the iodoplatinatc reagent of 
sulphur amino acids6 and the a-nitroso-/hnaphthol re­
agent of tyrosine7. In ascending paper chromatograms 
with the system n-butanol:acetic acid:water (4:1:1), 
physalaemin had Rf 0.41. On electropherograms it 
migrated towards the cathode at acid pH and showed no 
mobility at neutral pH. Acid hydrolysis yielded glutamic 
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and aspartic acids, alanine, proline, lysine, phenylalanine, 
tyrosine, glycine, leucine and methionine. Ten out of 
eleven residues were present in a 1:1 mole ratio, and 
only the aspartyl residue was found to be present in a 2:1 
ratio with respect to the other amino acids.
The sequence was elucidated through chemical and 
enzymatic degradation. Physalaemin, like eledoisin, was 
resistant to enzymatic attack at both the C and N termi­
nus. The Sanger and Edman techniques failed to reveal a 
free N-terminal residue. Upon digestion with chymo­
trypsin, the consecutive appearance of the following frag­
ments was observed in the reaction mixtures:
C4 [Glu, Ala, 2 Asp, Pro, Lys, Phe, Tyr], C2 [Gly, Leu, Met], 
C3 [Glu, Ala, 2 Asp, Pro], C4 [Lys, Phe, Tyr],
Cs [Lys, Phe], C6 H-Tyr-OH,
C7 [Gly, Leu] and C8 H-Met-NH2
It followed that chymotrypsin caused a rapid cleavage 
at the carboxyl bond of tyrosine with release of the C- 
terminal tripeptide C2, then a bond was split between the 
C end of the N-terminal pentapeptide and the amino 
group of lysine. Upon further action of the enzyme, 
tyrosine was slowly released from C4 and finally a very 
slow and incomplete splitting of methionamide from C2 
was observed.
Tryptic digestion was anomalous, since two bonds were 
split, one of which was a lysil and the other a tyrosil 
bond, and the rapid and simultaneous formation of the 
following three peptides was observed:
Tj [Glu, Ala, 2 Asp, Pro, Lys], T2 [Phe,Tyr] and T3 [Gly, Leu, Met]
From the above results the sequence of the C-terminal 
hexapeptide was deduced, the position of the single 
residues being established by the specificity of the en­
zymes and by the composition of the fragments. The se­
quence Gly-Leu was determined by the fluorodinitro­
benzene procedure on the tripeptide Gly-Leu-Met-NH2.
Under the action of carboxypeptidase lysine was slowly 
split from the tryptic hexapeptide T1( thus confirming the 
position of lysine already deduced by the specificity of 
trypsine cleavage. The sequence of the five N-terminal 
amino acids was found by submitting T4 to partial acid 
hydrolysis with 0.5 N acetic acid. The presence of the fol­
lowing fragments was consecutively observed in the acid 
hydrolysates:
Acj [Glu, Ala], Ac2 [H-Asp-(OH)2], Ac3 [Pro, Asp(NH2)]-Lys-OH, 
Ac4 Pyr-OH, Acs H-Ala-OH, Ac6 [Pro, Asp(NH)2] and H-Lys-OH
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The sequence -Pro-Asp-NH2 was deduced by the posi­
tive reaction to isatine of the spots Ac3 and Ac6. The 
status of the glutamyl and aspartyl residues was estab­
lished by the relative electrophoretic mobilities of the 
fragments in which they occurred.
Pharmacological actions. Physalaemin is a powerful 
vasodilator and hypotensive agent in dog and rabbit. It 
is 3 to 4 times as active as eledoisin. In the dog the i.v. 
threshold hypotensive dose is approximately 1 ng/kg. 
The pressure fall is proportional, both in intensity and 
even more in duration, to the dose of the polypeptide, 
and tachyphylaxis is completely lacking. A persistent, 
controllable lowering of blood pressure may be obtained 
with i.v. infusion of physalaemin, the threshold being 
2-5 ng/kg/min. An appreciable lowering of blood pressure 
is also produced by subcutaneous doses of 1 ¿zg/kg 
physalaemin. In the majority of experiments, hypotension 
produced by medium i.v. doses of physalaemin is of 
shorter duration than that produced by equiactive doses 
of eledoisin.
1 /zg physalaemin is capable of counteracting com­
pletely the hypertensive action of 50-100 /zg L-adrenaline 
or L-noradrenaline, 10-15 ¿zg angiotensin, 30-50 ¿zg Lys- 
8-vasopressin, or 3 mg nicotine. On a weight basis 
physalaemin is 100-700 times more potent than brady­
kinin, and 200-400 times more than histamine. The effect 
on the blood pressure of the dog and rabbit of 1 ¿zg 
physalaemin is equivalent to 100-200 units of sub­
stance P.
Both in the intact and in the decapitated chicken, 
physalaemin is predominantly hypertensive. Pressure 
rise seems to be mainly due to liberation of catechol­
amines.
In increasing the permeability of the skin vessels of the 
human forearm, physalaemin is slightly more active than 
eledoisin8.
Generally, physalaemin stimulates the same extra- 
vascular smooth muscles which are stimulated by ele­
doisin but, with the exception of the rabbit large intestine 
and the guinea-pig ileum, the effect is weaker than with 
eledoisin and tachyphylaxis is not infrequent. The rat 
uterus is poorly sensitive to physalaemin, and even the 
rabbit uterus is several times less responsive to physalae­
min than to eledoisin.
Large doses of physalaemin stimulate salivary secretion 
in the dog, but this effect seems less intense compared 
with eledoisin.
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Whole blood slowly inactivates physalaemin, homo­
genates of liver and kidney far more quickly. Generally, 
physalaemin is inactivated more rapidly than eledoisin9.
In parallel assays physalaemin may clearly be distin­
guished from known natural polypeptides active on plain 
muscle, including substance P and eledoisin, which in 
most of their biological properties are very similar to 
physalaemin.
Physalaemin or strictly related polypeptides are also 
contained in the skin extracts of Physalaemus centralis, 
Physalaemus bresslaui and Physalaemus cuvieri.
Full reports of the experiments and results described 
in this paper will be published elsewhere.
Riassunto. Viene descritto il procedimento che ha per­
messo l’isolamento e il chiarimento della struttura chimica 
della fisalemina, il principale dei polipeptidi attivi della 
pelle di Physalaemus fuscumaculatus, anfibio dell’Argen- 
tina. La fisalemina, strettamente vicina all’eledoisina 
anche da un punto di vista chimico è, come questa, dotata 
di potente azione sulla muscolatura liscia vasale ed extra- 
vasale. Essa è nettamente distinguibile, mediante saggi 
paralleli, da tutti gli altri polipeptidi biogeni finora noti.
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